Replies to post #170980 on Biotech Values

[jq1234]

No, both refers to CP-CML patients. Summary added additional qualifier of >=6 months dose reduction while table 2 didn't. Summary took numbers from table 3 where you can see number of patients in >=6 months subset is much smaller.